Published: Friday, November 22, 2024 · 6:01 PM | Updated: Friday, November 22, 2024 · 6:01 PM
📊 471 views
On November 21, 2024, CROSSLINK CAPITAL INC (Trades, Portfolio) executed a strategic transaction involving Weave Communications Inc, reducing its holdings by 212,031 shares. This move resulted in a -0.38% impact on the firm’s portfolio. The transaction was carried out at a trade price of $13.44 per share, leaving CROSSLINK CAPITAL INC (Trades, Portfolio) with a total of 8,376,683 shares in Weave Communications Inc. This adjustment reflects a significant portion of the firm’s portfolio, accounting for 15.18% of its total holdings and 11.11% of the firm’s stake in the stock.
Profile of CROSSLINK CAPITAL INC (Trades, Portfolio)
CROSSLINK CAPITAL INC (Trades, Portfolio), headquartered in San Francisco, CA, is a prominent investment firm with a focus on the technology and healthcare sectors. The firm manages an equity portfolio valued at $745 million, with top holdings in companies such as Nutanix Inc (NTNX, Financial), Penguin Solutions Inc (PENG, Financial), and Duolingo Inc (DUOL, Financial). The firm’s investment strategy emphasizes growth and innovation within its chosen sectors, leveraging its expertise to identify promising opportunities in the market.
Overview of Weave Communications Inc
Weave Communications Inc, trading under the symbol WEAV, is a USA-based company that went public on November 11, 2021. The company specializes in providing a customer experience and payments software platform tailored for small and medium-sized healthcare businesses. Weave Communications Inc primarily generates revenue through subscription services, offering a comprehensive solution that integrates various workflows to enhance patient engagement and streamline practice operations.
Financial Metrics and Valuation of Weave Communications Inc
Weave Communications Inc currently holds a market capitalization of approximately $984.594 million, with a stock price of $13.53. The stock is considered significantly overvalued, with a GF Value of $9.69, resulting in a Price to GF Value ratio of 1.40. This valuation suggests that the stock is trading above its intrinsic value, which may have influenced CROSSLINK CAPITAL INC (Trades, Portfolio)’s decision to reduce its holdings.
Performance and Growth Indicators
Weave Communications Inc has a GF Score of 55/100, indicating poor future performance potential. Despite this, the company has demonstrated a 3-year revenue growth of 21.20% and an EBITDA growth of 28.70%. However, the company faces challenges with a negative return on equity (ROE) of -38.54%, reflecting potential inefficiencies in generating profits from its equity base.
Implications of the Transaction
The reduction in shares by CROSSLINK CAPITAL INC (Trades, Portfolio) signifies a strategic decision, potentially driven by the stock’s overvaluation and its financial performance metrics. By adjusting its position in Weave Communications Inc, the firm may be seeking to optimize its portfolio in response to market conditions and the company’s valuation. This transaction leaves CROSSLINK CAPITAL INC (Trades, Portfolio) with a substantial stake in Weave Communications Inc, maintaining a significant influence over its investment strategy.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
MORE IN INSIDE INVESTMENT NEWS
CVS earnings Surge: Why This Turnaround is a Portfolio Game-Changer
Published: Wednesday, August 5, 2026 · 11:39 AM
Eli Lilly quarterly estimates Surge on Explosive GLP-1 Demand
Published: Wednesday, August 5, 2026 · 11:38 AM
